Minnesota-based HistoSonics has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration to begin its first clinical trial in the US. The study will be called #HOPE4LIVER.
The Foundation has partnered with the Blood Profiling Atlas in Cancer (BloodPAC) – a nonprofit consortium dedicated to advancing liquid biopsy research – to explore focused ultrasound’s potential in this burgeoning field.
Named for the Latin word for wave, Onda develops technologies to measure ultrasound waves. Petrie Yam, Onda’s Vice President of Sales, Marketing, and Operations, discusses how the company has been making a difference for 30 years.
Insightec’s Chairman and CEO, Maurice R. Ferré, MD, is a recipient of an Ernst & Young LLP’s Entrepreneur Of The Year® Florida Award, recognizing unstoppable entrepreneurial leaders transforming our world.